Differentiating Hypertensive Emergency from Hypertensive Urgency
The presence or absence of acute target‑organ damage—not the absolute blood pressure value—is the sole criterion that distinguishes hypertensive emergency from hypertensive urgency. 1, 2
Key Definitions
- Hypertensive emergency: Blood pressure >180/120 mmHg WITH evidence of new or worsening acute target‑organ damage, requiring immediate ICU admission and intravenous therapy 1, 2
- Hypertensive urgency: Blood pressure >180/120 mmHg WITHOUT acute target‑organ damage, managed with oral medications and outpatient follow‑up 1, 2
- The rate of blood pressure rise may be more clinically important than the absolute value; patients with chronic hypertension often tolerate higher pressures than previously normotensive individuals 1
Systematic Assessment for Target‑Organ Damage
Neurologic Damage
- Look for: Altered mental status, somnolence, lethargy, severe headache with vomiting, visual disturbances (cortical blindness, blurred vision), seizures, focal neurologic deficits, or coma 1, 2
- These findings indicate hypertensive encephalopathy, acute ischemic stroke, or intracranial hemorrhage 1, 2
Cardiac Damage
- Look for: Chest pain suggesting acute myocardial ischemia or infarction, dyspnea with pulmonary edema, signs of acute left ventricular failure, or unstable angina 1, 2
- Obtain troponin levels if chest pain is present and perform ECG to assess for ischemia or left ventricular hypertrophy 2
Vascular Damage
- Look for: Sudden severe chest or back pain radiating to the back, suggesting aortic dissection or aneurysm 1, 2
Renal Damage
- Look for: Acute deterioration in renal function (rising creatinine), oliguria, or new proteinuria 1, 2
- Laboratory tests should include creatinine, BUN, electrolytes, and urinalysis for protein and sediment 2
Ophthalmologic Damage (Malignant Hypertension)
- Perform fundoscopy looking for: Bilateral retinal hemorrhages, cotton‑wool spots, or papilledema (grade III–IV retinopathy) 1, 2
- Critical distinction: Isolated subconjunctival hemorrhage is NOT acute target‑organ damage 2
- Malignant hypertension requires bilateral advanced retinopathy findings, not unilateral or minor changes 2
Hematologic Damage (Thrombotic Microangiopathy)
- Laboratory screening: Complete blood count (hemoglobin, platelets), lactate dehydrogenase (LDH), and haptoglobin 2
- Thrombocytopenia with elevated LDH and decreased haptoglobin indicates microangiopathic hemolytic anemia 2
Obstetric Damage
- Look for: Severe preeclampsia or eclampsia in pregnant or postpartum patients (up to 42 days after delivery) 1, 2
Management Algorithm
If Target‑Organ Damage IS Present (Hypertensive Emergency)
Immediate Actions:
- Admit to ICU with continuous arterial‑line blood pressure monitoring (Class I recommendation) 1, 2
- Initiate intravenous antihypertensive therapy immediately 1, 2
Blood Pressure Targets (without compelling conditions):
- First hour: Reduce mean arterial pressure by 20–25% (or systolic by ≤25%) 1, 2
- Hours 2–6: Lower to ≤160/100 mmHg if patient remains stable 1, 2
- Hours 24–48: Gradually normalize blood pressure 1, 2
- Avoid systolic drops >70 mmHg, which can precipitate cerebral, renal, or coronary ischemia 1, 2
Blood Pressure Targets (with compelling conditions):
- Aortic dissection: SBP <120 mmHg within 20 minutes 1
- Severe preeclampsia/eclampsia or pheochromocytoma: SBP <140 mmHg within first hour 1
- Acute coronary syndrome or pulmonary edema: SBP <140 mmHg immediately 1
First‑Line IV Medications:
- Nicardipine (preferred for most emergencies except acute heart failure): Start 5 mg/h, increase by 2.5 mg/h every 15 minutes to maximum 15 mg/h 1, 2
- Labetalol (preferred for aortic dissection, eclampsia, malignant hypertension with renal involvement): 10–20 mg IV bolus over 1–2 minutes, repeat or double every 10 minutes (maximum cumulative 300 mg) 1, 2
If Target‑Organ Damage IS NOT Present (Hypertensive Urgency)
Immediate Actions:
- Do NOT admit to hospital 1, 2
- Do NOT use intravenous medications 1, 2
- Initiate or adjust oral antihypertensive therapy 1, 2
Blood Pressure Targets:
- First 24–48 hours: Gradually reduce to <160/100 mmHg 1, 2
- Subsequent weeks: Aim for <130/80 mmHg 1, 2
- Avoid rapid lowering, as this may cause cerebral, renal, or coronary ischemia in patients with chronic hypertension and altered autoregulation 1, 2
Preferred Oral Agents:
- Extended‑release nifedipine 30–60 mg PO 2
- Captopril 12.5–25 mg PO (caution in volume‑depleted patients) 2
- Labetalol 200–400 mg PO (avoid in reactive airway disease, heart block, bradycardia) 2
Follow‑Up:
Critical Pitfalls to Avoid
- Do not admit patients with asymptomatic severe hypertension without evidence of acute target‑organ damage 2
- Do not assume absence of symptoms equals absence of organ damage; a focused examination including fundoscopy is essential 2
- Do not use immediate‑release nifedipine, as it causes unpredictable precipitous drops, stroke, and death 1, 2
- Do not rapidly lower blood pressure in hypertensive urgency, as this may cause hypoperfusion‑related injury 1, 2
- Do not normalize blood pressure acutely in chronic hypertensives, as altered cerebral autoregulation predisposes to ischemic injury 1, 2
- Do not treat the blood pressure number alone in asymptomatic patients; many with acute pain or distress have transiently elevated pressures that normalize when the underlying condition is treated 3
- Up to one‑third of patients with diastolic blood pressure >95 mmHg normalize before arranged follow‑up, and rapid lowering may be harmful 2
Prognosis
- Untreated hypertensive emergencies carry a >79% one‑year mortality and median survival of only 10.4 months 1, 2
- After stabilization, 20–40% of patients with malignant hypertension have identifiable secondary causes (renal artery stenosis, pheochromocytoma, primary aldosteronism, renal parenchymal disease) requiring screening 1, 2
- Medication non‑adherence is the most common trigger for hypertensive emergencies 1, 2